Who founded Ikaika Therapeutics?

Ikaika Therapeutics was founded by Elizabeth McNally.

How much funding has Ikaika Therapeutics raised?

Ikaika Therapeutics has disclosed $1M raised across 1 round.

Where is Ikaika Therapeutics headquartered?

Ikaika Therapeutics is headquartered in Oak Park, US.

Ikaika Therapeutics

Oak Park, US · Delaware corporation

Find your way into Ikaika Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Ikaika Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Ikaika Therapeutics develops treatments for cardiovascular disease using genetic signals, with a focus on inherited forms of heart disease and neuromuscular genetic disorders such as myopathies and muscular dystrophy. The company applies research on the genetic causes and mechanisms of cardiac disorders to drive drug development.

Biotech Healthtech

Founders & leadership

Elizabeth McNallyFounder, CEO & Board Member

CHIH-KAO HUNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2021

▶$1MraisedNov 2021 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

CHIH-KAO HUDirector
ELIZABETH MCNALLYExecutive Officer, Director

Offering amount: $1.5M
Amount sold: $1M
First sale: Oct 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Ikaika Therapeutics do?: Ikaika Therapeutics develops treatments for cardiovascular disease using genetic signals, with a focus on inherited forms of heart disease and neuromuscular genetic disorders such as myopathies and muscular dystrophy. The company applies research on the genetic causes and mechanisms of cardiac disorders to drive drug development.
Who founded Ikaika Therapeutics?: Ikaika Therapeutics was founded by Elizabeth McNally.
How much funding has Ikaika Therapeutics raised?: Ikaika Therapeutics has disclosed $1M raised across 1 round.
Where is Ikaika Therapeutics headquartered?: Ikaika Therapeutics is headquartered in Oak Park, US.